※Washing the face and applying makeup are both possible on the day of treatment, though care should be taken to avoid rubbing the injected areas.

※Regarding Laennec (Human Placental Extract)
① Laennec is approved in Japan for the indication of "improving liver function in chronic liver disease." However, its use at our clinic for aesthetic care and general wellness purposes has not received approval under Japan's Pharmaceuticals and Medical Devices Act.
② Our clinic obtains this approved pharmaceutical product through licensed domestic pharmaceutical wholesalers and administers it under the professional judgment of our physicians.
③ While approved pharmaceutical products containing human placental extract as an active ingredient do exist in Japan, the approved indications, usage, and dosage differ from the purpose and method of use applied at our clinic.
④ Injectable formulations containing human placental extract undergo heat treatment and other measures during manufacturing as a precaution against infection; however, because the raw material is derived from human tissue, the risk of infection transmission cannot be entirely ruled out. Additionally, because the theoretical risk of vCJD (variant Creutzfeldt-Jakob disease) transmission cannot be completely excluded, individuals who have received injections containing human placental extract are no longer eligible to donate blood. Injection site reactions may include pain, redness, swelling, bruising, rash, fever, itching, and allergic reactions.
⑤ In the rare event of a serious adverse reaction, depending on the purpose and method of use, this treatment may not be eligible for compensation under Japan's national Relief System for Adverse Drug Reactions.